Hepatic Failure/GI/Endocrine Emergencies
Gastrointestinal Fistulas
Coughlin S, Roth L, Lurati G, Faulhaber M. Somatostatin
analogues for the treatment of enterocutaneous fistu-
las: a systematic review and meta-analysis. World J
Surg.
2012;36(5):1016-1029.
https://doi.org/10.1007/
s00268-012-1494-3
de Aguilar-Nascimento JE, Caporossi C, Dock-
Nascimento DB, de Arruda IS, Moreno K, Moreno
W. Oral glutamine in addition to parenteral nutrition
improves mortality and the healing of high-output intes-
tinal fistulas. Nutr Hosp. 2007;22(6):672-676.
Falconi M, Pederzoli P. The relevance of gastrointesti-
nal fistulae in clinical practice: a review. Gut. 2001;49
Suppl 4(Suppl 4):iv2-iv10. https://doi.org/10.1136/gut.49.
suppl_4.iv2
Gonzalez-Pinto I, Moreno Gonzalez E. Optimising
the treatment of upper gastrointestinal fistulae. Gut
2002;49:iv21-28.
Hesse U, Ysebaert D, de Hemptinne B. Role of soma-
tostatin-14 and its analogues in the management of
gastrointestinal fistulae: clinical data. Gut. 2001;49
Suppl 4(Suppl 4):iv11-iv21. https://doi.org/10.1136/gut.49.
suppl_4.iv11
Lévy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM,
Parc R. High-output external fistulae of the small bowel:
management with continuous enteral nutrition. Br
J Surg. 1989;76(7):676-679. https://doi.org/10.1002/
bjs.1800760708
Nubiola-Calonge P, Badía JM, Sancho J, Gil MJ, Segura
M, Sitges-Serra A. Blind evaluation of the effect of
octreotide (SMS 201-995), a somatostatin analogue, on
674. https://doi.org/10.1016/s0140-6736(87)92452-4
Parli SE, Pfeifer C, Oyler DR, Magnuson B, Procter
LD. Redefining “bowel regimen”: Pharmacologic strate-
gies and nutritional considerations in the management
https://doi.org/10.1016/j.amjsurg.2018.01.040
Polk TM, Schwab CW. Metabolic and nutritional sup-
port of the enterocutaneous fistula patient: a three-phase
approach. World J Surg. 2012;36(3):524-533. https://doi.
org/10.1007/s00268-011-1315-0
Schecter WP. Management of enterocutaneous fistu-
las. Surg Clin North Am. 2011;91(3):481-491. https://doi.
org/10.1016/j.suc.2011.02.004
Schecter WP, Hirshberg A, Chang DS, et al.
Enteric fistulas: principles of management. J Am
Coll Surg. 2009;209(4):484-491. https://doi.org/10.1016/j.
jamcollsurg.2009.05.025
Postoperative Ileus and Nausea/Vomiting
Apfel CC, Korttila K, Abdalla M, et al. A factorial trial
of six interventions for the prevention of postoperative
nausea and vomiting. N Engl J Med. 2004;350(24):2441-
2451. https://doi.org/10.1056/nejmoa032196
Asao T, Kuwano H, Nakamura J, Morinaga N, Hirayama
I, Ide M. Gum chewing enhances early recovery from
postoperative ileus after laparoscopic colectomy. J Am
Coll Surg. 2002;195(1):30-32. https://doi.org/10.1016/
s1072-7515(02)01179-1
Bell TJ, Poston SA, Kraft MD, Senagore AJ, Delaney
CP, Techner L. Economic analysis of alvimopan in North
Pharm. 2009;66(15):1362-1368. https://doi.org/10.2146/
ajhp080329
Cheatham ML, Chapman WC, Key SP, Sawyers
JL.
A
meta-analysis
of
selective
versus
rou-
tine
nasogastric
decompression
after
elective
org/10.1097/00000658-199505000-00004
Chen JY, Wu GJ, Mok MS, et al. Effect of adding
ketorolac to intravenous morphine patient-controlled
analgesia on bowel function in colorectal surgery
patients—a prospective, randomized, double-blind
study. Acta Anaesthesiol Scand. 2005;49(4):546-551.
https://doi.org/10.1111/j.1399-6576.2005.00674.x
Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan, for
postoperative ileus following bowel resection: a pooled
363. https://doi.org/10.1097/01.sla.0000232538.72458.93
De Oliveira GS Jr, Castro-Alves LJ, Ahmad S,
Kendall MC, McCarthy RJ. Dexamethasone to pre-
vent postoperative nausea and vomiting: an updated
meta-analysis of randomized controlled trials. Anesth
Analg.
2013;116(1):58-74.
https://doi.org/10.1213/
ane.0b013e31826f0a0a
Gan TJ, Apfel CC, Kovac A, et al. A randomized, dou-
ble-blind comparison of the NK1 antagonist, aprepitant,
versus ondansetron for the prevention of postopera-
tive nausea and vomiting. Anesth Analg. 2007;104(5):.
https://doi.org/10.1213/01.ane.0000263277.35140.a3